Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1F 18 T807----2件: 2, 127 💬
2F-18----3件: 5, 7, 127 💬
3F-18 3f4AP----1件: 13 💬
4F-18 AV 1451----2件: 5, 127 💬
5F-18 FDG----1件: 127 💬
6F-18 fpcit----1件: 6 💬
7F-dopa PET CT----1件: 75 💬
8F13CD----1件: 288 💬
9F18-AV-45----1件: 6 💬
10F18ceto----1件: 75 💬
11F8il10----2件: 46, 97 💬
12F8VR----1件: 288 💬
13FAB122----1件: 2 💬
14Fabrazyme1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
15Fabrazyme (agalsidase beta) 1 MG/KG1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
16Fabrazyme - 35 MG polvere PER concentrato PER soluzione PER infusione endovenosa 1 flaconcino1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
17Fabrazyme 35 MG1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
18Fabrazyme 5 MG1件: Agalsidase beta1件: Agalsidase beta 💬 1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
19Facs analyses----1件: 65 💬
20Factane 200 IU/ML----1件: 288 💬
21Factor viii concentrate1件: Beroctocog alfa---1件: 288 💬
22Factor VON willebrand1件: Von Willebrand factor human---1件: 288 💬
23Factor X1件: Coagulation factor X human---1件: 288 💬
24Factor xiia antagonist monoclonal antibody----2件: 65, 85 💬
25Factor xiia inhibitor monoclonal antibody----1件: 65 💬
26Factor xiii1件: Factor XIII (human)---3件: 51, 97, 288 💬
27Factor xiii concentrate (human), pasteurized1件: Factor XIII (human)---1件: 288 💬
28Faecal bacterial transplantation----1件: 97 💬
29Faecal matter----1件: 97 💬
30Faecal microbiota transplant----2件: 94, 97 💬
31Faecal microbiota transplantation----5件: 46, 84, 96, 97, 271 💬
32Faecal sampling----1件: 46 💬
33FAM therapy----1件: 228 💬
34FAMC-1----1件: 2 💬
35Famciclovir1件: Famciclovir1件: Famciclovir 💬 --2件: 11, 13 💬
36Famotidina1件: Famotidine1件: Famotidine 💬 1件: HRH2 💬 4件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 61 💬
37Famotidine1件: Famotidine1件: Famotidine 💬 1件: HRH2 💬 4件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬5件: 6, 46, 98, 145, 300 💬
38Famotidine 20 MG1件: Famotidine1件: Famotidine 💬 1件: HRH2 💬 4件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 86 💬
39Fampridina1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬
4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
40Fampridine1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬
4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14 💬
41Fampridine SR1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬
4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
42Fampridine-SR1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬
4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
43Fampyra1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬
4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14 💬
44Fampyra 10 MG prolonged-release tablets1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬
4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
45Fampyra 10MG prolonged release tablets----1件: 13 💬
46FAN beam CT scan----1件: 49 💬
47Fang1件: Gemogenovatucel-T---1件: 46 💬
48Fang YI qing feng SHI granule----1件: 46 💬
49Fanhdi----1件: 288 💬
50Fanhdi 100 UI----1件: 288 💬
51Fanhdi 100 UI fviii-120 UI FVW----1件: 288 💬
52Fanhdi 25 UI----1件: 288 💬
53Fanhdi 25 UI fviii-30 UI FVW----1件: 288 💬
54Fanhdi 250UI*1F 250UI+F 10ML----1件: 288 💬
55Fanhdi 50 UI----1件: 288 💬
56Fanhdi 50 UI fviii-60 UI FVW----1件: 288 💬
57Fanhdi*INF FL 250UI+SIR solv+S----1件: 288 💬
58Fanhdi*INF FL 500UI+SIR solv+S----1件: 288 💬
59Fanhdi*INF FL1000UI+SIR solv+S----1件: 288 💬
60Fanhdi*INF FL250UI+SIR solv+S----1件: 288 💬
61Fasenra1件: Benralizumab1件: Benralizumab 💬 1件: IL5RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299 💬
62Fasting blood test----1件: 6 💬
63Fasudil1件: Fasudil2件: Fasudil hydrochloride ,
Fasudil 💬
2件: ROCK1,
ROCK2 💬
24件: Adherens junction, Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 2, 5, 7, 51 💬
64Fasudil hydrochloride1件: Fasudil2件: Fasudil hydrochloride ,
Fasudil 💬
2件: ROCK1,
ROCK2 💬
24件: Adherens junction, Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 2, 6 💬
65FAT soluble vitamins supplementation----1件: 299 💬
66FAT stem cell----1件: 96 💬
67Fatigue----1件: 13 💬
68Fatigue and daytime sleepiness scale----1件: 113 💬
69Faxe kondi free----1件: 257 💬
70Fazirsiran1件: Fazirsiran---1件: 231 💬
71Fazirsiran (TAK-999, also referred TO AS ARO-AAT) injection1件: Fazirsiran---1件: 231 💬
72Fazirsiran (TAK-999, ARO-AAT) injection1件: Fazirsiran---1件: 231 💬
73Fazisiran injection----1件: 231 💬
74FB-1011件: FB-101---1件: 6 💬
75FB1006----1件: 2 💬
76FB418----2件: 2, 6 💬
77FB704A----1件: 46 💬
78FBL-MTX----1件: 46 💬
79FBS0701 capsule----1件: 284 💬
80FBS0701/SSP004184----1件: 284 💬
81FBX-1011件: FBX-101---1件: 19 💬
82FC- and CDR-modified humanised monoclonal antibody against C5----3件: 11, 62, 109 💬
83FCM----1件: 222 💬
84FCN-159----1件: 34 💬
85FCR blocker OF autoantibodies----1件: 51 💬
86FCR0011件: FCR001---1件: 51 💬
87FCX-007----1件: 36 💬
88FCX-007 (dabocemagene autoficel----1件: 36 💬
89FCX-0131件: FCX-013---1件: 51 💬
90FDC macitentan/tadalafil2件: Macitentan,
Tadalafil
2件: Tadalafil ,
Macitentan 💬
3件: EDNRA,
EDNRB,
PDE5 💬
10件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
91FDG----2件: 41, 84 💬
92FDG PET scan----2件: 6, 85 💬
93FDG-PET----3件: 5, 6, 7 💬
94FDG-PET/CT with RB82 myocardial perfusion imaging----1件: 84 💬
95FDL1691件: FDL169---1件: 299 💬
96FDL176----1件: 299 💬
97FDL176 & FDL169 coadministration----1件: 299 💬
98FE 992097----1件: 193 💬
99FE 999301----2件: 96, 97 💬
100Fear OF falling----1件: 13 💬
101Feasibility OF BETA-hydroxybutyrate supplementation TO reduce inflammation IN patients with crohn'S----2件: 96, 97 💬
102Feburane----1件: 21 💬
103Febuxostat1件: Febuxostat2件: Febuxostat ,
Febuxostat hydrate 💬
1件: XDH 💬 4件: Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬4件: 2, 6, 13, 97 💬
104Fecal microbial L transplantation----1件: 97 💬
105Fecal microbial transplant----3件: 46, 96, 97 💬
106Fecal microbial transplantation----2件: 96, 97 💬
107Fecal microbial transplants----1件: 13 💬
108Fecal microbiome----1件: 61 💬
109Fecal microbiome probiotic----1件: 294 💬
110Fecal microbiota1件: Fecal microbiota---5件: 13, 49, 93, 96, 97 💬
111Fecal microbiota capsule1件: Fecal microbiota---1件: 97 💬
112Fecal microbiota enema1件: Fecal microbiota---1件: 97 💬
113Fecal microbiota transfer provided BY human biome institute1件: Fecal microbiota---1件: 6 💬
114Fecal microbiota transplant1件: Fecal microbiota---3件: 6, 96, 97 💬
115Fecal microbiota transplantation1件: Fecal microbiota---10件: 2, 6, 13, 63, 66, 94, 96, 97, 99, 271 💬
116Fecal microbiota transplantation (FMT) OF FMP30 donor stool1件: Fecal microbiota---1件: 13 💬
117Fecal microbiota transplantation (FMT), openbiome1件: Fecal microbiota---1件: 97 💬
118Fecal microbiota transplantation BY intra-rectal enemas1件: Fecal microbiota---1件: 97 💬
119Fecal microbiota transplantation BY stool capsules1件: Fecal microbiota---1件: 97 💬
120Fecal microbiota transplantation capsules1件: Fecal microbiota---1件: 97 💬
121Fecal transplantation----1件: 97 💬
122Felzartamab1件: Felzartamab---2件: 66, 222 💬
123Femoston 1/10----1件: 13 💬
124Femoston 2/10----1件: 13 💬
125Fendrix suspension FOR injection1件: Hepatitis B Vaccine (Recombinant)---1件: 46 💬
126Fendrix, suspensióN inyectable----1件: 97 💬
127Fenebrutinib1件: Fenebrutinib1件: Fenebrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 13 💬
128Fenfluramina cloridrato1件: Fenfluramine2件: Fenfluramine hydrochloride ,
Fenfluramine 💬
5件: HTR1,
HTR2,
HTR2,
SIGMAR1,
SLC6A4 💬
11件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬2件: 140, 144 💬
129Fenfluramine1件: Fenfluramine2件: Fenfluramine hydrochloride ,
Fenfluramine 💬
5件: HTR1,
HTR2,
HTR2,
SIGMAR1,
SLC6A4 💬
11件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬4件: 140, 144, 145, 149 💬
130Fenfluramine HCL, DL-fenfluramine, (±)-fenfluramine1件: Fenfluramine2件: Fenfluramine hydrochloride ,
Fenfluramine 💬
5件: HTR1,
HTR2,
HTR2,
SIGMAR1,
SLC6A4 💬
11件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬1件: 144 💬
131Fenfluramine hydrochloride1件: Fenfluramine2件: Fenfluramine hydrochloride ,
Fenfluramine 💬
5件: HTR1,
HTR2,
HTR2,
SIGMAR1,
SLC6A4 💬
11件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬2件: 140, 144 💬
132Fengshigutong capsule plus imrecoxib----1件: 271 💬
133Fenilbutirato----1件: 2 💬
134Fenofibrate1件: Fenofibrate1件: Fenofibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬6件: 8, 79, 93, 94, 97, 265 💬
135Fenofibrate 160MG1件: Fenofibrate1件: Fenofibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 97 💬
136Fenofibrate 200MG1件: Fenofibrate1件: Fenofibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
137Fenofibrate combined with ursodeoxycholic acid2件: Fenofibrate,
Ursodeoxycholic acid
2件: Fenofibrate ,
Ursodiol 💬
2件: NR1C1,
NR1H4 💬
11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
138Fenofibrate IN combination with ursodeoxycholic acid1件: Fenofibrate1件: Fenofibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
139Fenretinide1件: Fenretinide1件: Fenretinide 💬 2件: RARA,
RARB 💬
8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 299 💬
140Fentanyl1件: Fentanyl3件: Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬
1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬5件: 46, 70, 97, 231, 298 💬
141Fentanyl (LOW dose) + dexmedetomidine1件: Fentanyl3件: Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬
1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 215 💬
142Fentanyl B. braun1件: Fentanyl3件: Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬
1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 97 💬
143Fentanyl transdermal patch1件: Fentanyl3件: Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬
1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 46 💬
144Feraccru1件: Ferric maltol1件: Ferric maltol 💬 --1件: 97 💬
145Feraheme----1件: 13 💬
146Feramyl----1件: 97 💬
147Ferinject1件: Ferric carboxymaltose1件: Ferric carboxymaltose 💬 --3件: 86, 97, 299 💬
148Ferinject - 50 MG/ML soluzione iniettabile O PER infusione 1 flaconcino IN vetro DA 10 ML----1件: 97 💬
149Ferinject 50 MG /ML. solucióN inyectable Y para perfusióN1件: Ferric carboxymaltose1件: Ferric carboxymaltose 💬 --1件: 97 💬
150Ferinject 50 MG eisen/ML1件: Ferric carboxymaltose1件: Ferric carboxymaltose 💬 --1件: 97 💬
151Ferinject 50 MG iron/ML solution FOR injection and infusion1件: Ferric carboxymaltose1件: Ferric carboxymaltose 💬 --1件: 97 💬
152Ferinject or cosmofer----1件: 86 💬
153Ferlixit - 62.5 MG/5 ML soluzione PER USO orale E USO endovenoso 5 fiale DA 5 ML----1件: 97 💬
154Fermented oyster extract----1件: 84 💬
155Ferracru----1件: 97 💬
156Ferric carboxy maltose----2件: 96, 97 💬
157Ferric carboxymaltose1件: Ferric carboxymaltose1件: Ferric carboxymaltose 💬 --4件: 86, 96, 97, 299 💬
158Ferric derisomaltose1件: Ferric derisomaltose1件: Ferric derisomaltose 💬 --1件: 97 💬
159Ferric gluconate1件: Ferrous gluconate2件: Ferric gluconate ,
Ferrous gluconate 💬
--1件: 97 💬
160Ferric maltol1件: Ferric maltol1件: Ferric maltol 💬 --2件: 96, 97 💬
161Ferric trimaltol----1件: 97 💬
162Ferricarboxymaltose----1件: 86 💬
163Ferriprox1件: Deferiprone1件: Deferiprone 💬 --1件: 121 💬
164Ferriprox 500 MG1件: Deferiprone1件: Deferiprone 💬 --1件: 6 💬
165Ferriprox*100CPR RIV 500MG1件: Deferiprone1件: Deferiprone 💬 --1件: 121 💬
166Ferrisat----1件: 97 💬
167Ferrisat 50MG/ML----1件: 97 💬
168Ferro duretter, prolonged release tablet----1件: 97 💬
169Ferro E.V. (come carbossimaltoso ferrico) - ferinject----1件: 97 💬
170Ferrofumaraat apotex----1件: 97 💬
171Ferrofumaraat teva----1件: 97 💬
172Ferrograd folic tablets----1件: 46 💬
173Ferrous fumarate1件: Ferrous fumarate---1件: 97 💬
174Ferrous fumarate syrup1件: Ferrous fumarate---1件: 97 💬
175Ferrous sulfate 325MG----1件: 299 💬
176Ferrous sulfate tablets----1件: 97 💬
177Ferrous sulphate----2件: 96, 97 💬
178Ferrous sulphate 200MG oral tablet----1件: 227 💬
179Ferrous sulphate with 65 MG iron++ PER tablet1件: Iron1件: Ferrous fumarate 💬 --1件: 97 💬
180Ferulic acid1件: Ferulic acid---1件: 127 💬
181Ferumoxytol1件: Ferumoxytol1件: Ferumoxytol 💬 --2件: 13, 226 💬
182Ferumoxytol infusion1件: Ferumoxytol1件: Ferumoxytol 💬 --1件: 13 💬
183Fesoterodine1件: Fesoterodine2件: Fesoterodine ,
Fesoterodine fumarate 💬
2件: CHRM2,
CHRM3 💬
14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
184Fetal porcine cells, neurocell-PD----1件: 6 💬
185Fexofenadine1件: Fexofenadine2件: Fexofenadine hydrochloride ,
Fexofenadine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬4件: 6, 13, 19, 46 💬
186FFP104----2件: 93, 96 💬
187FG-3019----3件: 85, 113, 222 💬
188FG-3019 10MG/ML IN 10 ML vials----1件: 85 💬
189Fibrate treatment----1件: 160 💬
190Fibrin1件: Fibrin---1件: 279 💬
191Fibrin adhesive1件: Fibrin---1件: 97 💬
192Fibrin glue injection IN fistula1件: Fibrin---1件: 96 💬
193Fibrinogen1件: Fibrinogen human1件: Fibrinogen I 125 💬 --1件: 107 💬
194Fibrinogen concentrate1件: Fibrinogen human1件: Fibrinogen I 125 💬 --1件: 14 💬
195Fibrinogen concentrate from human plasma1件: Fibrinogen human1件: Fibrinogen I 125 💬 --1件: 65 💬
196Fibrinogen plasma concentration, coagulation factor xiii activity1件: Fibrinogen human1件: Fibrinogen I 125 💬 --1件: 288 💬
197Fibrinogen TO albumin ratio and C-reactive TO albumin ratio1件: Fibrinogen human1件: Fibrinogen I 125 💬 --1件: 49 💬
198Fibrogammin----1件: 288 💬
199Fibrogammin P----1件: 288 💬
200Fibrogammin® 1250----1件: 51 💬
201Fibrogammin® P----1件: 288 💬
202Fibrogammin®P----1件: 288 💬
203Fibroscan----1件: 171 💬
204Fibrovein----1件: 279 💬
205Fidaxomicin1件: Fidaxomicin1件: Fidaxomicin 💬 --1件: 97 💬
206Fidaxomicina1件: Fidaxomicin1件: Fidaxomicin 💬 --1件: 97 💬
207Fidrisertib1件: Fidrisertib1件: Fidrisertib 💬 1件: ACVR1 💬 5件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hormone signaling, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 272 💬
208Fidrisertib (IPN60130) 10 MG capsules1件: Fidrisertib1件: Fidrisertib 💬 1件: ACVR1 💬 5件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hormone signaling, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 272 💬
209Fidrisertib (IPN60130) 50 MG capsules1件: Fidrisertib1件: Fidrisertib 💬 1件: ACVR1 💬 5件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hormone signaling, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 272 💬
210Fidsertib----1件: 272 💬
211FIG1件: Fig---1件: 2 💬
212Filgotinib1件: Filgotinib2件: Filgotinib ,
Filgotinib maleate 💬
4件: JAK1,
JAK2,
JAK3,
TYK2 💬
39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬
213Filgotinib 200MG/DAY1件: Filgotinib2件: Filgotinib ,
Filgotinib maleate 💬
4件: JAK1,
JAK2,
JAK3,
TYK2 💬
39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
214Filgotinib maleate1件: Filgotinib2件: Filgotinib ,
Filgotinib maleate 💬
4件: JAK1,
JAK2,
JAK3,
TYK2 💬
39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 46, 97 💬
215Filgrastim1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬29件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
216Filgrastim hexal1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 65 💬
217FILM-coated tablet----2件: 96, 97 💬
218Filsuvez----1件: 36 💬
219Fimepinostat1件: Fimepinostat1件: Fimepinostat 💬 11件: HDAC10,
HDAC1_2,
HDAC1_2,
HDAC3,
HDAC4_5,
HDAC4_5,
HDAC6,
HDAC7,
HDAC8,
HDAC9,
PIK3C3 💬
32件: ATP-dependent chromatin remodeling, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Inositol phosphate metabolism, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phagosome, Phosphatidylinositol signaling system, Polycomb repressive complex, Salmonella infection, Shigellosis, Spinocerebellar ataxia, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis 💬1件: 75 💬
220Finamine tablets----1件: 6 💬
221Finasteride1件: Finasteride1件: Finasteride 💬 1件: SRD5A2 💬 2件: Prostate cancer, Steroid hormone biosynthesis 💬1件: 6 💬
222Finely ground flaxseed powder----1件: 299 💬
223Finerenone1件: Finerenone1件: Finerenone 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬4件: 66, 218, 222, 224 💬
224Fingolimob----1件: 13 💬
225Fingolimod1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬
1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156 💬
226Fingolimod 0.5 MG1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬
1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
227Fingolimod 0.5MG1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬
1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
228Fingolimod 1.25 MG1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬
1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
229Fingolimod hydrochloride1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬
1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
230Fingolimodi----1件: 13 💬
231Fingolmod----1件: 13 💬
232Fipamezole1件: Fipamezole---2件: 6, 17 💬
233Fipamezole hydrochloride 30 MG oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
234Fipamezole hydrochloride 60 MG oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
235Fipamezole hydrochloride 90 MG oral disintegrating tablets1件: Fipamezole---2件: 6, 17 💬
236Fipamezole ODT1件: Fipamezole---1件: 6 💬
237Fipamezole ODT cohort 21件: Fipamezole---1件: 6 💬
238Firategrast1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
239Firategrast 150 MG1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
240Firategrast 300 MG1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
241Firategrast gastro-retentive solution1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
242Firategrast immediate release tablet1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
243Firategrast modified release tablet1件: Firategrast1件: Firategrast 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
244Firazyr1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
245Firazyr (icatibant) 30 MG solution FOR injection IN PRE filled syringe1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
246Firazyr 30 MG solucióN inyectable EN jeringa precargada1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
247Firazyr 30 MG solution FOR injection IN PRE-filled syringe1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
248Firazyr*SC 1SIR 30MG 3ml10MG/M1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
249Firazyr® 30 MG subcutaneous injection syringe: 3.0 ML×1 syringe1件: Icatibant1件: Icatibant acetate 💬 1件: BDKRB2 💬 10件: Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬
250Firdapse - 10 MG - compresse - USO orale - blister(ALU/PVC/pvdc) 100 X 1 compresse----2件: 3, 11 💬
251First line DMT----1件: 13 💬
252First-line biologic:IFX----1件: 97 💬
253First-line biologic:VDZ----1件: 97 💬
254First-line cognitive assessment----1件: 3 💬
255Fisetin1件: Fisetin---1件: 65 💬
256Fish assay----1件: 28 💬
257Fish intake----1件: 46 💬
258Fish OIL1件: Fish oil---5件: 13, 46, 49, 96, 299 💬
259Fish OIL capsule1件: Fish oil---1件: 79 💬
260Fish OIL concentrate1件: Fish oil---1件: 13 💬
261Fish OIL supplement1件: Fish oil---1件: 46 💬
262Fish OIL, gamma-linolenic acid1件: Fish oil---1件: 46 💬
263Fish OIL, rich IN omega-3-acids1件: Fish oil---1件: 13 💬
264Fish OIL,rich IN omega 3 acids1件: Fish oil---1件: 13 💬
265Fitbit activity monitor----1件: 49 💬
266FITC-adalimumab----2件: 96, 97 💬
267Fixed dose combination ciprofloxacin/celecoxib----1件: 2 💬
268FK-506----1件: 60 💬
269FK506----1件: 222 💬
270FK506 level 2-3 NG/ML----1件: 86 💬
271FK506 level 3-5 NG/ML----1件: 86 💬
272FK506 level < 2 NG/ML----1件: 86 💬
273FKB327----1件: 46 💬
274FKB327 AI----1件: 46 💬
275FKB327 PFS----1件: 46 💬
276FKC288----1件: 222 💬
277Flagyl1件: Metronidazole2件: Metronidazole ,
Metronidazole hydrochloride 💬
--2件: 96, 97 💬
278Flash glucose monitoring system----1件: 49 💬
279Flavocoxid----1件: 113 💬
280Flavoxate1件: Flavoxate2件: Flavoxate hydrochloride ,
Flavoxate 💬
16件: PDE1,
PDE1,
PDE1,
PDE10,
PDE11,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE7,
PDE7,
PDE8,
PDE8 💬
17件: Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
281Flebogamma 5% DIF----1件: 65 💬
282Flecainide + BETA-blocker1件: Flecainide2件: Flecainide acetate ,
Flecainide 💬
5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 115 💬
283Flecainide acetate1件: Flecainide2件: Flecainide acetate ,
Flecainide 💬
5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
284Flecainidum1件: Flecainide2件: Flecainide acetate ,
Flecainide 💬
5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
285Flexibility and postural exercise----1件: 299 💬
286Flexibility and strengthening exercise----1件: 6 💬
287Flixabi1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
288Flolan injection with currently marketed diluent----1件: 86 💬
289Flolan injection with reformulated diluent----1件: 86 💬
290Flolan TM and glycine diluent1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬
1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
291Flolan™ and glycine diluent1件: Epoprostenol2件: Epoprostenol ,
Epoprostenol sodium 💬
1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
292Florbetapir 18F----1件: 127 💬
293Florbetapir 18F injection----1件: 127 💬
294Florbetapir F 18----1件: 6 💬
295Florence 30 µG/ML----1件: 98 💬
296Florence 60 µG/ML----1件: 98 💬
297Florence 90 µG/ML----1件: 98 💬
298Flortaucipir F181件: Flortaucipir1件: Flortaucipir F 18 💬 1件: MAPT 💬 4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬3件: 5, 7, 127 💬
299Floseal----1件: 227 💬
300Flovent----1件: 98 💬
301Flow cytometry----6件: 28, 41, 51, 60, 65, 285 💬
302FLOW-mediated dilation OF THE brachial artery----1件: 49 💬
303FLT1901件: FLT190---1件: 19 💬
304FLT2011件: FLT201---1件: 19 💬
305FLU-ATG----1件: 60 💬
306FLU/CY/ATG or CY/ATG----1件: 60 💬
307Flucinolone acetonide----1件: 56 💬
308Flucloxacillin1件: Flucloxacillin2件: Flucloxacillin sodium ,
Floxacillin 💬
--1件: 299 💬
309Flucloxacillin 250MG/5ML sugar-free powder FOR oral solution1件: Flucloxacillin2件: Flucloxacillin sodium ,
Floxacillin 💬
--1件: 299 💬
310Flucloxacillin sodium1件: Flucloxacillin2件: Flucloxacillin sodium ,
Floxacillin 💬
--1件: 299 💬
311Flucloxicillin----1件: 299 💬
312Fluconazole1件: Fluconazole1件: Fluconazole 💬 --2件: 96, 225 💬
313Fludara1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
314Fludarabina accord1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
315Fludarabina accord - 25 MG/ML concentrato PER soluzione iniettabile O PER infusione 5 flaconcini IN vetro DA 2 ML1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 19 💬
316Fludarabina fosfato1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 19 💬
317Fludarabina teva - 25 MG/ML concentrato PER soluzione iniettabile O PER infusione 1 flaconcino DI vetro DA 2 ML1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
318Fludarabine1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬23件: 11, 13, 19, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 326 💬
319Fludarabine monophosphate1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬3件: 65, 284, 326 💬
320Fludarabine phosphate1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬12件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 💬
321Fludarabine phosphate 30 MG1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164 💬
322Fludarabine phosphate 40 MG1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 164 💬
323Fludarabine phosphate FOR injection1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
324Fludarabine, busulfan, thymoglobulin1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
325Fludarabine, cyclophosphamide1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
326Fludarabine, melphalan, thiotepa1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 65 💬
327Fludarabine/ melphalan1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
328Fludarabine/busulfan1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬
1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
329Fludeoxyglucose1件: Fludeoxyglucose---1件: 88 💬
330Fludeoxyglucose F 182件: Fludeoxyglucose,
Fludeoxyglucose (18F)
1件: Fludeoxyglucose F 18 💬 --1件: 34 💬
331Fludrocortisone1件: Fludrocortisone2件: Fludrocortisone acetate ,
Fludrocortisone 💬
1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬3件: 6, 17, 81 💬
332Fluid biopsy capsule----1件: 6 💬
333Fluid restriction----1件: 72 💬
334Fluimucil----1件: 193 💬
335Fluimucil*20CPR EFF 600MG----2件: 94, 298 💬
336Fluimucil® 600 MG effervescent tablets----1件: 85 💬
337Flumazenil1件: Flumazenil1件: Flumazenil 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬5件: 6, 13, 17, 18, 206 💬
338Fluocinolone acetonide2件: Fluocinolone,
Fluocinolone acetonide
1件: Fluocinolone acetonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 90 💬
339Fluorescein1件: Fluorescein2件: Fluorescein ,
Fluorescein sodium 💬
--2件: 22, 97 💬
340Fluorescein and indocyanine green angiography1件: Fluorescein2件: Fluorescein ,
Fluorescein sodium 💬
--1件: 41 💬
341Fluorescein angiography1件: Fluorescein2件: Fluorescein ,
Fluorescein sodium 💬
--2件: 19, 41 💬
342Fluorescence imaging----2件: 46, 97 💬
343Fluorescence IN situ hybridization----1件: 285 💬
344Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration OF unlabeled vedolizumab1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬
16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
345Fluorescence molecular imaging procedure without prior administration OF vedolizumab-800CW1件: Vedolizumab1件: Vedolizumab 💬 2件: ITGA4,
ITGB7 💬
16件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97 💬
346Fluorescite----1件: 215 💬
347Fluorine (18F) fludeoxyglucose----1件: 84 💬
348Fluorine F 18 clofarabine----4件: 40, 46, 49, 96 💬
349Fluorine-181件: Fluorine F-181件: Sodium fluoride F 18 💬 --1件: 41 💬
350Fluoro[18F]promethazine----1件: 6 💬
351Fluorodeoxyglucose----1件: 84 💬
352Fluoroscopic swallow evaluation----1件: 6 💬
353Fluoroscopy----1件: 6 💬
354Fluoxetin hexal1件: Fluoxetine2件: Fluoxetine ,
Fluoxetine hydrochloride 💬
1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13 💬
355Fluoxetine1件: Fluoxetine2件: Fluoxetine ,
Fluoxetine hydrochloride 💬
1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬3件: 13, 17, 86 💬
356Fluoxetine hydrochloride1件: Fluoxetine2件: Fluoxetine ,
Fluoxetine hydrochloride 💬
1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13 💬
357Fluoxétine1件: Fluoxetine2件: Fluoxetine ,
Fluoxetine hydrochloride 💬
1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 17 💬
358Flupentixol1件: Flupentixol3件: Flupentixol ,
Flupentixol dihydrochloride ,
Flupentixol decanoate 💬
2件: DRD1,
DRD2 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 97 💬
359Flupirtin----1件: 13 💬
360Flupirtine1件: Flupirtine2件: Flupirtine maleate ,
Flupirtine 💬
--1件: 13 💬
361Flupirtinmaleat----1件: 13 💬
362Flurbiprofen1件: Flurbiprofen2件: Flurbiprofen ,
Flurbiprofen sodium 💬
2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬3件: 13, 21, 46 💬
363Flutamide1件: Flutamide1件: Flutamide 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 81 💬
364Flutemetamol1件: Flutemetamol---4件: 5, 6, 7, 127 💬
365Flutemetamol F18 injection2件: Flutemetamol,
Flutemetamol (18F)
1件: Flutemetamol F 18 💬 --5件: 5, 6, 7, 17, 127 💬
366Fluticasone1件: Fluticasone1件: Fluticasone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 98, 228, 299 💬
367Fluticasone MDI1件: Fluticasone1件: Fluticasone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
368Fluticasone propionate2件: Fluticasone,
Fluticasone propionate
2件: Fluticasone propionate ,
Fluticasone 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 98, 228, 306 💬
369Fluticasone propionate, USP2件: Fluticasone,
Fluticasone propionate
2件: Fluticasone propionate ,
Fluticasone 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
370Fluvastatin1件: Fluvastatin2件: Fluvastatin sodium ,
Fluvastatin 💬
1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬2件: 79, 222 💬
371Fluzone----1件: 49 💬
372FLX-787-ODT----1件: 2 💬
373FMP-30----1件: 53 💬
374FMT----3件: 96, 97, 271 💬
375FMT enema----1件: 97 💬
376FMT infusions----1件: 97 💬
377FMT oral----1件: 97 💬
378FMT protocol----1件: 97 💬
379FNP-223----1件: 5 💬
380Focetria----3件: 46, 49, 271 💬
381FOG----1件: 6 💬
382Folacin1件: Folic acid2件: Folic acid ,
Folate sodium 💬
--2件: 96, 97 💬
383Folate1件: Folic acid2件: Folic acid ,
Folate sodium 💬
--2件: 41, 46 💬
384Folic (or folinic) acid----1件: 46 💬
385Folic acid1件: Folic acid2件: Folic acid ,
Folate sodium 💬
--6件: 46, 84, 96, 97, 172, 296 💬
386Folic acid 1 MG1件: Folic acid2件: Folic acid ,
Folate sodium 💬
--1件: 6 💬
387Folic acid or folate1件: Folic acid2件: Folic acid ,
Folate sodium 💬
--1件: 46 💬
388Folic acid tablet1件: Folic acid2件: Folic acid ,
Folate sodium 💬
--1件: 6 💬
389Folic acid, vitamin B6, vitamin B121件: Folic acid2件: Folic acid ,
Folate sodium 💬
--1件: 6 💬
390Folic/folinic acid----2件: 46, 107 💬
391Foliglurax1件: Foliglurax---1件: 6 💬
392Folimet----1件: 46 💬
393Folinic acid1件: Leucovorin3件: Leucovorin calcium ,
Folinic acid ,
Folinic acid calcium salt pentahydrate 💬
--2件: 46, 320 💬
394Follow-UP study OF THE treated cohort----1件: 193 💬
395Follow-UP study OF THE untreated cohort----1件: 193 💬
396Fontolizumab1件: Fontolizumab1件: Fontolizumab 💬 1件: IFNG 💬 32件: African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 46 💬
397Food diary----1件: 65 💬
398Food groups and nutrients----1件: 46 💬
399Foralumab1件: Foralumab---2件: 13, 96 💬
400Foralumab nasal1件: Foralumab---1件: 17 💬
401Foralumab TZLS-401 100 µG1件: Foralumab---1件: 13 💬
402Foralumab TZLS-401 50 µG1件: Foralumab---1件: 13 💬
403Fordadistrogene movaparvovec1件: Fordadistrogene movaparvovec---1件: 113 💬
404Forigerimod1件: Forigerimod1件: Forigerimod 💬 --1件: 49 💬
405Forlax 4 G, poudre pour solution buvable EN sachet----1件: 299 💬
406Formalin-fixed paraffin-embedded (ffpe) tissue samples analysis1件: Formaldehyde1件: Formaldehyde 💬 --1件: 98 💬
407Formistin - 10 MG compresse rivestite CON film 20 compresse----1件: 13 💬
408Formistin 10 MG----1件: 13 💬
409Formoterol1件: Formoterol2件: Formoterol fumarate ,
Formoterol 💬
1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 306 💬
410Formoterol fumarate dihydrate1件: Formoterol2件: Formoterol fumarate ,
Formoterol 💬
1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
411Formoterol/budesonide1件: Formoterol2件: Formoterol fumarate ,
Formoterol 💬
1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 228 💬
412Formula----1件: 96 💬
413Formulation A----1件: 13 💬
414Formulation B----1件: 13 💬
415Formulation C----1件: 13 💬
416Formulation D----1件: 13 💬
417Forsteo1件: Teriparatide3件: Teriparatide acetate ,
Teriparatide ,
Teriparatide acetate 💬
1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬3件: 70, 235, 274 💬
418Forsteo-R----1件: 235 💬
419Fortecortin----1件: 28 💬
420Forteo1件: Teriparatide3件: Teriparatide acetate ,
Teriparatide ,
Teriparatide acetate 💬
1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 70 💬
421Forteo 20 MG----1件: 235 💬
422Fortiral----1件: 6 💬
423Fortum----1件: 299 💬
424Forxiga1件: Dapagliflozin1件: Dapagliflozin 💬 --2件: 86, 88 💬
425FOS----2件: 66, 96 💬
426Foscarbidopa1件: Foscarbidopa1件: Foscarbidopa 💬 --1件: 6 💬
427Foscarbidopa and foslevodopa2件: Foscarbidopa,
Foslevodopa
2件: Foslevodopa ,
Foscarbidopa 💬
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
428Foscarnet1件: Foscarnet1件: Foscarnet sodium 💬 --1件: 60 💬
429Foscarnet sodium1件: Foscarnet1件: Foscarnet sodium 💬 --2件: 28, 60 💬
430Fosd----1件: 46 💬
431Fosfamatinib disodium----1件: 46 💬
432Fosfato sodico DE dexametasona1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 96 💬
433Fosfomycin1件: Fosfomycin3件: Fosfomycin tromethamine ,
Fosfomycin sodium ,
Fosfomycin 💬
--2件: 96, 97 💬
434Fosigotifator1件: Fosigotifator1件: Fosigotifator 💬 5件: EIF2B1,
EIF2B2,
EIF2B3,
EIF2B4,
EIF2B5 💬
1件: Herpes simplex virus 1 infection 💬2件: 2, 308 💬
435Foslevodopa1件: Foslevodopa1件: Foslevodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
436Fosmetpantotenate----1件: 121 💬
437Fosmetpantotenate drug substance----1件: 121 💬
438Fosmetpantotenato----1件: 121 💬
439Fospropofol (lusedra®) 101件: Fospropofol1件: Fospropofol disodium 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 226 💬
440Fospropofol (lusedra®) 6.51件: Fospropofol1件: Fospropofol disodium 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 226 💬
441Fostair----1件: 85 💬
442Fostamatinib1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬3件: 46, 49, 63 💬
443Fostamatinib 100 MG1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
444Fostamatinib 100 MG tablet1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
445Fostamatinib 150 MG1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
446Fostamatinib 150 MG BID1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 61 💬
447Fostamatinib 150 MG tablet1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
448Fostamatinib 50 MG blue FILM-coated tablet1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
449Fostamatinib disodium1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬4件: 46, 61, 63, 66 💬
450Fostamatinib disodium / R9357881件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 63 💬
451Fostamatinib disodium 100 MG1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 63 💬
452Fostamatinib disodium 150 MG1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 63 💬
453Fostamatinib disodium tablet 100 MG1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
454Fostamatinib disodium tablet 150 MG1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
455Fostamatinib disodium tablets1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 63 💬
456Four square step test----2件: 6, 13 💬
457FP-045----1件: 285 💬
458FP-110----1件: 97 💬
459FP-CYA-050----1件: 97 💬
460FP-CYA-053----1件: 97 💬
461FPA008----1件: 46 💬
462FPFS-1169----1件: 6 💬
463FPI-2620----1件: 127 💬
464FR104----1件: 46 💬
465Fractionated carbon dioxide (FCO2) laser----1件: 50 💬
466Fragment antibody targeting human TFR1 conjugated TO phosphorodiamidate morpholino oligomer----1件: 113 💬
467Fragmin1件: Dalteparin1件: Dalteparin sodium 💬 1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬1件: 222 💬
468Frameshift array blood sample test----1件: 34 💬
469Free amino acids intake----1件: 240 💬
470Free diet----1件: 97 💬
471Freeze dried grape powder----2件: 96, 97 💬
472Freeze-dried black raspberry powder----1件: 97 💬
473Fremanezumab1件: Fremanezumab1件: Fremanezumab 💬 1件: CALC 💬 3件: Hormone signaling, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬2件: 124, 226 💬
474Fresh frozen plasma----2件: 5, 14 💬
475Fresolimumab1件: Fresolimumab1件: Fresolimumab 💬 3件: TGFB1,
TGFB2,
TGFB3 💬
36件: AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, Efferocytosis, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬3件: 51, 222, 274 💬
476Frexalimab1件: Frexalimab1件: Frexalimab 💬 1件: TNFSF5 💬 14件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬2件: 13, 222 💬
477Frisium*30CPS 10MG----1件: 140 💬
478FRM-0334----1件: 127 💬
479Frondanol----1件: 97 💬
480Froniglutide1件: Froniglutide---1件: 50 💬
481Fructose1件: Fructose1件: Fructose 💬 --1件: 179 💬
482Fructose and galactose1件: Fructose1件: Fructose 💬 --1件: 257 💬
483Fructose sachet1件: Fructose1件: Fructose 💬 --1件: 97 💬
484Fruit and vegetables intake----1件: 46 💬
485Fruit juice----1件: 299 💬
486FSME-immun----1件: 46 💬
487FT-002----1件: 90 💬
488FT011 100 MG----1件: 51 💬
489FT011 200 MG----1件: 51 💬
490FT819----2件: 49, 51 💬
491FTI, azli----1件: 299 💬
492FTX-1821----1件: 113 💬
493FTY720----1件: 13 💬
494FTY720D----1件: 13 💬
495FTY720I----1件: 14 💬
496Fucidin tablets1件: Fusidic acid2件: Fusidic acid ,
Fusidic acid hemihydrate 💬
--1件: 299 💬
497Full history , clinical examination, assesment OF disease activity ,laboratory investigations ( CBC , ESR, CRP serum creatinine and blood urea, random plas----2件: 46, 49 💬
498Full spectrum vitamin----1件: 13 💬
499Fully human ANTI-interferon gamma monoclonal antibody----1件: 107 💬
500Fully human IGG1 monoclonal antibody specific FOR TL1A----2件: 96, 97 💬
501Fully human IGG2 lambda monoclonal antibody----1件: 172 💬
502Fully human monoclonal antibody directed against CXCL10----1件: 93 💬
503Fully humanized ANTI-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody----1件: 13 💬
504Fultium-D3 800IU capsules----1件: 274 💬
505Fulvestrant1件: Fulvestrant1件: Fulvestrant 💬 2件: ESR1,
ESR2 💬
10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 86 💬
506Fumaderm® initial----1件: 49 💬
507Functional and antigenic C1 inhibitor----1件: 65 💬
508Functional assessment questionnaires----1件: 41 💬
509Functional balance intervention----1件: 13 💬
510Functional hepatic nitrogen clearance----1件: 171 💬
511Functional index-2----1件: 113 💬
512Functional involvement OF identified epigenetic alterations----1件: 102 💬
513Functional magnetic resonance imaging----1件: 6 💬
514Functional mobility----2件: 6, 13 💬
515Functional oral intake scale----1件: 2 💬
516Functional reach test----2件: 6, 13 💬
517Functional residual capacity----1件: 294 💬
518Fundus autofluorescence----1件: 41 💬
519Furestem-RA INJ----1件: 46 💬
520Furosemide1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬2件: 77, 86 💬
521Furosemide injection1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 6 💬
522Fursultiamine1件: Fursultiamine2件: Fursultiamine ,
Fursultiamine hydrochloride 💬
--1件: 6 💬
523Fusidic acid1件: Fusidic acid2件: Fusidic acid ,
Fusidic acid hemihydrate 💬
--1件: 299 💬
524Fusidin----1件: 299 💬
525Fuzhenghuayu----1件: 93 💬
526FX-1006A1件: Fx-1006A---1件: 28 💬
527FX125L----1件: 46 💬
528Fxiia inhibitor monoclonal antibody----2件: 65, 85 💬
529Fycompa1件: Perampanel2件: Perampanel ,
Perampanel hydrate 💬
4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬
17件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬2件: 2, 144 💬